Rennova Health, Inc.
RNVA
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -44.62% | 29.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -44.62% | 29.97% | |||
| Cost of Revenue | -1.50% | -1.02% | |||
| Gross Profit | -61.99% | 48.72% | |||
| SG&A Expenses | -3.52% | 6.41% | |||
| Depreciation & Amortization | -42.86% | 5.63% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.57% | 3.08% | |||
| Operating Income | -128.66% | 178.86% | |||
| Income Before Tax | -141.05% | 123.63% | |||
| Income Tax Expenses | -135.69% | -- | |||
| Earnings from Continuing Operations | -143.20% | 59.46% | |||
| Earnings from Discontinued Operations | 86.42% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 464.29% | -- | |||
| Net Income | -142.90% | 58.61% | |||
| EBIT | -128.66% | 178.86% | |||
| EBITDA | -124.78% | 159.56% | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 4.90% | 0.60% | |||
| Average Diluted Shares Outstanding | -93.49% | -5.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
